Over the last 7 days, the Life Sciences industry has dropped 2.0%, driven by EirGenix declining 4.5%. However, the industry is down 17% over the past year. As for the next few years, earnings are expected to grow by 2.4% per annum.
Has the Taiwanese Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 24 Jul 2024 | NT$43.1b | NT$2.1b | -NT$797,765,000.00 | 33.3x | -54x | 20.2x |
Fri, 21 Jun 2024 | NT$42.3b | NT$2.1b | -NT$797,765,000.00 | 34.3x | -53.1x | 19.8x |
Sun, 19 May 2024 | NT$40.7b | NT$2.1b | -NT$794,421,000.00 | 32.1x | -51.3x | 19.1x |
Tue, 16 Apr 2024 | NT$40.1b | NT$2.1b | -NT$903,875,000.00 | 30.5x | -44.4x | 19x |
Thu, 14 Mar 2024 | NT$40.5b | NT$2.1b | -NT$611,249,000.00 | 32.1x | -66.2x | 19.6x |
Sat, 10 Feb 2024 | NT$43.0b | NT$2.1b | -NT$610,218,000.00 | 32.4x | -70.4x | 20.7x |
Mon, 08 Jan 2024 | NT$46.5b | NT$2.1b | -NT$610,218,000.00 | 34.4x | -76.3x | 22.4x |
Wed, 06 Dec 2023 | NT$48.6b | NT$2.1b | -NT$610,218,000.00 | 34.1x | -79.6x | 23.4x |
Fri, 03 Nov 2023 | NT$48.8b | NT$2.2b | -NT$497,769,000.00 | 31.8x | -98.1x | 21.9x |
Sun, 01 Oct 2023 | NT$48.0b | NT$2.2b | -NT$497,769,000.00 | 31.3x | -96.4x | 21.6x |
Tue, 29 Aug 2023 | NT$43.3b | NT$2.2b | -NT$497,769,000.00 | 31.1x | -87x | 19.5x |
Thu, 27 Jul 2023 | NT$47.8b | NT$2.5b | -NT$274,767,000.00 | 42.4x | -174.1x | 19.5x |
Sat, 24 Jun 2023 | NT$48.4b | NT$2.5b | -NT$274,767,000.00 | 43.2x | -176.1x | 19.7x |
Mon, 22 May 2023 | NT$50.1b | NT$2.6b | -NT$38,534,000.00 | 41.9x | -1299x | 19.1x |
Wed, 19 Apr 2023 | NT$50.9b | NT$2.7b | -NT$29,761,000.00 | 24.5x | -1710.8x | 19.1x |
Fri, 17 Mar 2023 | NT$46.6b | NT$2.7b | NT$82.4m | 23.5x | 566x | 17.6x |
Sun, 12 Feb 2023 | NT$52.8b | NT$2.7b | NT$85.3m | 19.8x | 619x | 19.7x |
Tue, 10 Jan 2023 | NT$48.0b | NT$2.7b | NT$85.3m | 18.8x | 563.4x | 18x |
Thu, 08 Dec 2022 | NT$57.7b | NT$2.7b | NT$139.5m | 18.7x | 413.9x | 21.6x |
Sat, 05 Nov 2022 | NT$42.4b | NT$3.0b | NT$482.8m | 24.4x | 87.9x | 14.2x |
Mon, 03 Oct 2022 | NT$45.0b | NT$3.0b | NT$482.8m | 23.7x | 93.2x | 15x |
Wed, 31 Aug 2022 | NT$53.9b | NT$3.0b | NT$482.8m | 28.1x | 111.5x | 18x |
Fri, 29 Jul 2022 | NT$41.1b | NT$3.1b | NT$325.1m | 37.8x | 126.4x | 13.4x |
Sun, 26 Jun 2022 | NT$42.1b | NT$3.1b | NT$325.1m | 36.3x | 129.6x | 13.7x |
Tue, 24 May 2022 | NT$30.6b | NT$3.1b | NT$325.1m | 34.9x | 94.3x | 10x |
Thu, 21 Apr 2022 | NT$36.3b | NT$3.2b | NT$164.4m | 27.9x | 220.8x | 11.4x |
Sat, 19 Mar 2022 | NT$33.3b | NT$3.0b | -NT$115,919,000.00 | 25.2x | -286.9x | 10.9x |
Mon, 14 Feb 2022 | NT$36.8b | NT$3.0b | -NT$120,147,000.00 | 35.4x | -306.6x | 12.1x |
Wed, 12 Jan 2022 | NT$38.1b | NT$3.0b | -NT$120,147,000.00 | 35.7x | -317.2x | 12.5x |
Fri, 10 Dec 2021 | NT$39.4b | NT$3.0b | -NT$120,147,000.00 | 37.1x | -327.8x | 12.9x |
Sun, 07 Nov 2021 | NT$29.7b | NT$2.8b | -NT$511,386,000.00 | 23.2x | -58.2x | 10.5x |
Tue, 05 Oct 2021 | NT$31.5b | NT$2.3b | -NT$631,150,000.00 | 31.8x | -49.9x | 13.5x |
Thu, 02 Sep 2021 | NT$34.9b | NT$2.3b | -NT$631,150,000.00 | 32.1x | -55.3x | 15x |
Sat, 31 Jul 2021 | NT$35.9b | NT$2.3b | -NT$631,150,000.00 | 32.4x | -56.9x | 15.4x |
-56.9x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | -4.61% | |
Healthcare | -0.93% | |
Life Sciences | -1.98% | |
Clinical Research and Equipment | -1.98% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6891 Locus Cell | NT$29.05 | 3.8% +NT$210.0m | -18.5% | PS7155.2x | |
6661 Welgene BiotechLtd | NT$33.50 | 13.0% +NT$89.7m | 45.7% | PS2.6x | |
6986 HeXun Biosciences | NT$72.50 | 0.7% +NT$23.0m | n/a | n/a |